As 2025 comes to an end, one thing is clear: global health didn’t move in straight lines this year.
Instead of a single dominant threat, epidemiologists spent 2025 managing layers of risk — resurgent respiratory viruses, persistent vector-borne diseases, sporadic outbreaks of high-consequence pathogens, and ongoing surveillance gaps. The year reminded us that public health is rarely about “the next big thing.” More often, it’s about what never went away.
Influenza returned strongly in multiple regions. Dengue continued to expand geographically. Polio remained under global surveillance. And viral hemorrhagic fevers reappeared where ecological conditions allow spillover. None of this was unexpected — but much of it was underestimated.
Perhaps the most important lesson of 2025 is this: preparedness depends less on prediction and more on continuity. Surveillance systems, vaccination programs, laboratory capacity, and trained personnel matter most when headlines fade.
Epidemiology in 2025 was not about dramatic breakthroughs. It was about endurance — and the cost of losing focus between crises.
